WebMD Health Corp (WBMD) Drops 7.92% on February 08

Equities Staff |

WebMD Health Corp (WBMD) was one of the Russell 2000's biggest losers for Monday February 08 as the stock slid 7.92% to $47.90, a loss of $-4.12 per share. Starting at an opening price of $51.39 a share, the stock traded between $47.72 and $52.51 over the course of the trading day. Volume was 1.04 million shares over 9,163 trades, against an average daily volume of 646,368 shares and a total float of 37.48 million.

The losses send WebMD Health Corp down to a market cap of $1.8 billion. In the last year, WebMD Health Corp has traded between $58.25 and $37.57, and its 50-day SMA is currently $48.55 and 200-day SMA is $44.73.

The stock has a P/E Ratio of 41.

WebMD Health Corp provides health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals and health-focused publications.

WebMD Health Corp is based out of New York, NY and has some 1,700 employees. Its CEO is David J. Schlanger.

For a complete fundamental analysis analysis of WebMD Health Corp, check out Equities.com’s Stock Valuation Analysis report for WBMD. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…